In people with coronary artery disease, variations in the IL18 gene consistently affect circulating levels of IL-18 and clinical outcomes, supporting the idea that IL-18 contributes to atherosclerosis and its consequences [28]. This evidence concerns the gene IL18 and atherosclerosis.